Through rapid immunochromatographic analysis, it is used to qualitatively detect whether the nasopharyngeal swabs of patients with suspected novel coronavirus pneumonia (COVID-19) within 5 days have nucleocapsid of novel coronavirus (SARS-CoV-2) protein antigens.
Not enough stock.
Your item was not added to your cart.
Not enough stock.
Please adjust your quantity.
Limit {{ product.max_order_quantity }} per order.
Only {{ quantityOfStock }} item(s) left.
*Made in Taiwan
*Accuracy >95%
*Results in 10 minutes
*Approved by Taiwan Ministry of Health and Welfare
*Has obtained EU CE certificate, international ISO and TFDA certification